MedPath

West Tennessee Eye Care, P.C.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1%

Phase 4
Completed
Conditions
Inflammation
Pseudophakia
Interventions
First Posted Date
2011-03-08
Last Posted Date
2020-10-28
Lead Sponsor
Toyos Clinic
Target Recruit Count
23
Registration Number
NCT01310127
© Copyright 2025. All Rights Reserved by MedPath